探索结核病人类挑战模型的伦理
Abie Rohrig1,2,3, Josh Morrison2, Gavriel Kleinwaks2
1Columbia University, New York, New York, USA.
Journal of medical ethics
|December 30, 2023
概括
对结核病 (TB) 的人类挑战试验可以加速疫苗开发. 伦理考虑,包括参与者和第三方风险,对于结核病疫苗研究至关重要,可以挽救数百万人的生命.
科学领域:
- 医学伦理学医学伦理学
- 传染病研究传染病研究.
- 疫苗的研发工作正在进行中.
背景情况:
- 人类挑战试验越来越多地被讨论为加速疫苗开发.
- 关于参与者和第三方风险的伦理问题限制了结核病 (TB) 挑战研究.
- 结核病带来了独特的伦理挑战,因为疾病负担很高,缺乏高效的疫苗.
研究的目的:
- 分析结核病疫苗开发人类挑战试验的伦理考虑和社会价值.
- 将结核病挑战模型进行比较,并确定与其他挑战试验的关键伦理差异.
- 评估结核病挑战试验对疫苗可用性和挽救生命的潜在影响.
主要方法:
- 分析与不同结核病挑战模型相关的预期社会价值和风险.
- 鉴定和评估结核病特有的伦理考虑,包括疾病负担,第三方风险,生物安全,治疗风险和检测困难.
- 对潜在的诱导剂进行审查,例如Bacillus Calmette-Guérin或Mycobacterium tuberculosis的减弱菌株.
主要成果:
- 结核病挑战试验有10%-50%的早期疫苗授权机会,可以在10年内挽救26,400至1100,000人的生命.
- 关键的伦理考虑区分结核病包括高疾病负担,缺乏有效的疫苗,第三方风险增加,严格的生物安全需求,治疗风险和检测挑战.
- 像Bacillus Calmette-Guérin或Mycobacterium tuberculosis这样的减弱菌株是结核病挑战试验的潜在候选人.
结论:
- 结核病挑战试验通过加速开发更有效的疫苗,为社会提供了重要的潜在价值.
- 仔细考虑独特的伦理因素,包括严格的生物安全措施,对于负责任地进行结核病挑战试验至关重要.
- 通过减弱菌株进行结核病挑战试验,需要认真考虑推进结核病疫苗研究.
更多相关视频
09:23Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019
11.9K
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
19.9K
相关概念视频
Ethics in Research
23.0K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.0K
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332
Pulmonary Tuberculosis II
240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
